Anne Lynns Chang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Experts discuss when to use the PD-1 inhibitor cemiplimab vs the hedgehog inhibitor vismodegib as neoadjuvant treatment in non-melanoma skin cancers.

United statesUniversity of california san franciscoVishala patelRebeccai hartmanAnne lynns changMichaelr migdenSarah arronJohnm strasswimmerDermatology associates of the palm beachesDepartment of dermatologyPeninsula dermatology medical group in burlingameHarvard medical schoolGw cancer centerRegeneron pharmaceuticals incUniversity of texas md anderson cancer centerEuropean union